Related Experiment Videos
Raising expectations for arthritis treatment. Biologic response modifiers are making remission possible
1Division of Rheumatology, Mayo Clinic, Jacksonville, FL 32224, USA. cohen.marc@mayo.edu
Postgraduate Medicine
|December 8, 2004
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Baricitinib in rheumatoid arthritis: evidence-to-date and clinical potential.
Therapeutic advances in musculoskeletal disease·2017
Rituximab for Rheumatoid Arthritis.
Rheumatology and therapy·2016
Eosinophilic fasciitis: clinical characteristics and response to methotrexate.
International journal of rheumatic diseases·2014
Intravenous golimumab in rheumatoid arthritis.
Expert review of clinical immunology·2014
Cell-signaling therapy in rheumatoid arthritis.
Current rheumatology reports·2013
Rheumatoid arthritis disease measurement: a new old idea.
Rheumatology (Oxford, England)·2012
Ponatinib in CML and Ph+ ALL: balancing high efficacy with vascular safety.
Postgraduate medicine·2026
CV risk: if you aren't testing ACR, you aren't seeing the full picture.
Postgraduate medicine·2026
Anti-TNF-induced vasculitis: analysis of data from the French national pharmacovigilance database.
Postgraduate medicine·2026
Unilateral uniportal endoscopy with unilateral fixation for lumbar degenerative diseases: A retrospective observational study and technical note.
The Journal of international medical research·2026
Macrophage-Derived Extracellular Vesicles Deliver Progranulin to Alleviate Skin Wound Fibrosis.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2026
LncRNA SNHG14 drives alveolar inflammation in bronchopulmonary dysplasia via DNMT3a-mediated epigenetic silencing of miR-214-3p.
Inflammation research : official journal of the European Histamine Research Society ... [et al.]·2026
Legionella effector RavH is a tandem WH2-like domain-containing PI(3)P-dependent actin nucleator.
Life science alliance·2026